JP Morgan Maintains Overweight on Braze, Raises Price Target to $35

Benzinga Newsdesk www.benzinga.com Positive 72.7%

Neg 0% Neu 0% Pos 72.7%

JP Morgan analyst Alexei Gogolev maintains Braze (NASDAQ:BRZE) with a Overweight and raises the price target from $33 to $35.